ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

INZY Inozyme Pharma Inc

4,66
-0,22 (-4,51%)
Zuletzt aktualisiert: 20:20:14
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Inozyme Pharma Inc INZY NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,22 -4,51% 4,66 20:20:14
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,79 4,551 4,84 4,88
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
07.5.202414:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.5.202414:32EDGAR2Form 8-K - Current report
07.5.202414:30GLOBEInozyme Pharma Reports First Quarter 2024 Financial Results..
03.5.202414:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
08.4.202412:30GLOBEInozyme Pharma Announces Positive Topline Data from Ongoing..
06.4.202400:00GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
02.4.202414:30GLOBEInozyme Pharma to Participate at the 23rd Annual Needham..
26.3.202413:30GLOBEInozyme Pharma to Report Topline Data from Ongoing Phase 1/2..
12.3.202413:30GLOBEInozyme Pharma Reports Full Year 2023 Financial Results and..
26.2.202414:30GLOBEInozyme Pharma to Participate in the TD Cowen 44th Annual..
14.2.202414:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202403:06EDGAR2Form SC 13D/A - General statement of acquisition of..
06.2.202414:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
05.12.202314:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
16.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
09.11.202314:30GLOBEInozyme Pharma to Participate in Upcoming Investor..
07.11.202322:07EDGAR2Form S-3 - Registration statement under Securities Act of..
07.11.202314:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202314:31EDGAR2Form 8-K - Current report
07.11.202314:30GLOBEInozyme Pharma Reports Third Quarter 2023 Financial Results..
03.11.202321:15GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
26.10.202314:30GLOBEInozyme Pharma Announces Presentation at the American..
10.10.202314:30GLOBEInozyme Pharma Highlights Inclusion of Generalized Arterial..
06.10.202314:30GLOBEInozyme Pharma Announces Three Poster Presentations at the..
03.10.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.9.202322:12EDGAR2Form 8-K - Current report
26.9.202313:30GLOBEInozyme Pharma Announces Positive Interim Data from Ongoing..
20.9.202314:30GLOBEInozyme Pharma to Host Virtual Investor and Analyst Event on..
06.9.202314:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
05.9.202314:30GLOBEInozyme Pharma to Present at the H.C. Wainwright 25th Annual..
11.8.202322:08EDGAR2Form SC 13D/A - General statement of acquisition of..
08.8.202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202314:37EDGAR2Form 8-K - Current report
08.8.202314:30GLOBEInozyme Pharma Reports Second Quarter 2023 Financial Results..
08.8.202303:58EDGAR2Form SC 13D/A - General statement of acquisition of..
04.8.202302:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202322:01GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
01.8.202322:01GLOBEInozyme Pharma, Inc. Announces Closing of Public Offering of..
28.7.202323:19EDGAR2Form 8-K - Current report
28.7.202323:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28.7.202305:20GLOBEInozyme Pharma, Inc. Announces Pricing of Public Offering of..
27.7.202323:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27.7.202322:33GLOBEInozyme Pharma, Inc. Announces Proposed Offering of Common..
26.7.202313:42EDGAR2Form 8-K - Current report
26.7.202313:30GLOBEInozyme Pharma Announces Updates on Global Development..
19.7.202314:30GLOBEInozyme Pharma to Provide ENPP1 Deficiency Program Update on..
27.6.202314:30GLOBEInozyme Pharma Announces Dosing of First Infant with ENPP1..
02.6.202313:30GLOBEInozyme Pharma to Present at the Jefferies Healthcare..
09.5.202314:30GLOBEInozyme Pharma Reports First Quarter 2023 Financial Results..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock